IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KCK Ltd.

Q2 2023 Holdings

Filed 2023-07-25 | 3 holdings | $63.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sight Sciences Inc(SGHT)COM82657M105$38.5M4,651,16560.4%
Neuropace Inc(NPCE)COM641288105$25.2M5,621,11139.6%
Aileron Therapeutics Inc(RNTX)COM NEW00887A204$40.0K22,3410.1%